Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bourdette

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Digestive Diseases and Sciences|January 1, 1979
Twelve-year history of gastrointestinal bleeding in a patient with calcific aortic stenosis and hemorrhagic telangiectasiaD Bourdette, B Greenberg
Neurology|October 1, 1983
Hypertrophic neuropathy and multiple sclerosisN L Rosenberg, D Bourdette
Journal of Neuroimmunology|July 1, 1994
Evidence for genetic contamination of inbred buffalo rats (RT-1b) obtained from a commercial vendorR E Jones, A Weinberg, D Bourdette
Journal of Neuroimmunology|July 30, 1999
Monitoring relapsing remitting MS patientsD Bourdette, J Antel, H McFarland, et al.
Journal of Neuroimmunology|April 1, 1992
The synthetic 87-99 peptide of myelin basic protein is encephalitogenic in Buffalo ratsR E Jones, D Bourdette, H Offner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2011
American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot studyE Kim, M Cameron, J Lovera, et al.
Complementary Therapies in Medicine|December 13, 2005
The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosisL Shinto, V Yadav, C Morris, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosisL Shinto, V Yadav, C Morris, et al.
Neurology|April 1, 1992
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research GroupD E Goodkin, D Cookfair, K Wende, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up studyR A Bermel, B Weinstock-Guttman, D Bourdette, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Digestive Diseases and Sciences|January 1, 1979
Twelve-year history of gastrointestinal bleeding in a patient with calcific aortic stenosis and hemorrhagic telangiectasiaD Bourdette, B Greenberg
Neurology|October 1, 1983
Hypertrophic neuropathy and multiple sclerosisN L Rosenberg, D Bourdette
Journal of Neuroimmunology|July 1, 1994
Evidence for genetic contamination of inbred buffalo rats (RT-1b) obtained from a commercial vendorR E Jones, A Weinberg, D Bourdette
Journal of Neuroimmunology|July 30, 1999
Monitoring relapsing remitting MS patientsD Bourdette, J Antel, H McFarland, et al.
Journal of Neuroimmunology|April 1, 1992
The synthetic 87-99 peptide of myelin basic protein is encephalitogenic in Buffalo ratsR E Jones, D Bourdette, H Offner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 2, 2011
American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot studyE Kim, M Cameron, J Lovera, et al.
Complementary Therapies in Medicine|December 13, 2005
The perceived benefit and satisfaction from conventional and complementary and alternative medicine (CAM) in people with multiple sclerosisL Shinto, V Yadav, C Morris, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Demographic and health-related factors associated with complementary and alternative medicine (CAM) use in multiple sclerosisL Shinto, V Yadav, C Morris, et al.
Neurology|April 1, 1992
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research GroupD E Goodkin, D Cookfair, K Wende, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 20, 2010
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up studyR A Bermel, B Weinstock-Guttman, D Bourdette, et al.
Pageof 3